Literature DB >> 15291973

What is the clinically relevant endpoint for cancer prevention trials?

Maurie Markman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15291973     DOI： 10.1007/s11912-004-0056-8

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN： 1523-3790            Impact factor:   5.075


× No keyword cloud information.
  7 in total

1.  Latent carcinoma and atypical lesions of prostate. An autopsy study.

Authors:  A Billis
Journal:  Urology       Date:  1986-10       Impact factor: 2.649

2.  Quality of life in women at risk for ovarian cancer who have undergone risk-reducing oophorectomy.

Authors:  Mark Robson; Martee Hensley; Richard Barakat; Carol Brown; Dennis Chi; Elizabeth Poynor; Kenneth Offit
Journal:  Gynecol Oncol       Date:  2003-05       Impact factor: 5.482

3.  Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen.

Authors:  L Bergman; M L Beelen; M P Gallee; H Hollema; J Benraadt; F E van Leeuwen
Journal:  Lancet       Date:  2000-09-09       Impact factor: 79.321

Review 4.  Chemoprevention of breast cancer: a summary of the evidence for the U.S. Preventive Services Task Force.

Authors:  Linda S Kinsinger; Russell Harris; Steven H Woolf; Harold C Sox; Kathleen N Lohr
Journal:  Ann Intern Med       Date:  2002-07-02       Impact factor: 25.391

5.  Latent prostatic cancer in a consecutive autopsy series.

Authors:  B Hølund
Journal:  Scand J Urol Nephrol       Date:  1980

6.  The influence of finasteride on the development of prostate cancer.

Authors:  Ian M Thompson; Phyllis J Goodman; Catherine M Tangen; M Scott Lucia; Gary J Miller; Leslie G Ford; Michael M Lieber; R Duane Cespedes; James N Atkins; Scott M Lippman; Susie M Carlin; Anne Ryan; Connie M Szczepanek; John J Crowley; Charles A Coltman
Journal:  N Engl J Med       Date:  2003-06-24       Impact factor: 91.245

7.  Prevalence of latent prostate carcinoma in two U.S. populations.

Authors:  J M Guileyardo; W D Johnson; R A Welsh; K Akazaki; P Correa
Journal:  J Natl Cancer Inst       Date:  1980-08       Impact factor: 13.506
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.